Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.7449
+0.0398 (5.64%)
At close: Aug 12, 2026, 4:00 PM EDT
0.7401
-0.0048 (-0.64%)
After-hours: Aug 12, 2026, 4:04 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $32.06 million as of August 12, 2026. Its market cap has increased by 2.47% in one year.
Market Cap
32.06M
Enterprise Value
30.13M
1-Year Change
2.47%
Ranking
Category
Stock Price
$0.74
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $32.06M, an increase of 1,703.34%. That is a compound annual growth rate of 113.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 32.06M | -45.59% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 32.48M |
| Quince Therapeutics | 32.01M |
| NanoViricides | 30.98M |
| Enlivex | 30.85M |
| Genenta Science | 30.67M |
| Lite Strategy | 30.66M |
| BriaCell Therapeutics | 29.85M |
| Kyntra Bio | 28.62M |